Companies
HI
STOXX 600Health Care· Europe
HIK
Hikma Pharmaceuticals
$1,379.00
+2.68%
Open $1,350.00·Prev $1,343.00
as of 17 Apr
ANALYSIS PENDING
Power Core
Structural analysis in progress
Published12 Apr 2026
UniverseSTOXX 600
SectorHealth Care
—
Direction of Movement
---
ROC 200
-32.6%
HIK
Hikma Pharmaceuticals
$1,379.00
+2.68%
Open $1,350.00·Prev $1,343.00
as of 17 Apr
↑Undervalued by 62%
DCF Fair Value: $3,588.04
Analysis Coming Q3/Q4 2026
News
No recent news available.
mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.